<s> Prevention and treatment of Doc_89511_28_47_Disease in climacteric women receiving Doc_89511_79_88_Chemical therapy. </s>
<s> The treatment regimens are described in 74 patients with Doc_89511_155_174_Disease among 850 climacteric women receiving Doc_89511_213_222_Chemical therapy. </s>
<s> Cystic Doc_89511_239_250_Disease was associated with unopposed Doc_89511_281_290_Chemical therapy without Doc_89511_307_318_Chemical. </s>
<s> Two courses of 21 days of 5 mg Doc_89511_351_365_Chemical daily caused reversion to normal in all 57 cases of cystic Doc_89511_425_436_Disease and 6 of the 8 cases of atypical Doc_89511_470_481_Disease. 4 cases of Doc_89511_494_515_Disease referred from elsewhere demonstrated the problems of inappropriate and unsupervised unopposed Doc_89511_610_619_Chemical therapy and the difficulty in distinguishing severe Doc_89511_672_683_Disease from Doc_89511_689_699_Disease. </s>
<s> Cyclical low-dose Doc_89511_719_728_Chemical therapy with 7--13 days of Doc_89511_756_767_Chemical does not seem to increase the risk of Doc_89511_806_829_Disease or Doc_89511_833_842_Disease. </s>
